Hydromorphone Hydrochloride 00641-6206
Product NDC
00641-6206- Manufacturer
- Hikma Pharmaceuticals Usa Inc.
- Dosage Form
- Injection
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- April 26, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA216899
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | .5 mg/.5mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(1)
10 SYRINGE in 1 CARTON (0641-6206-10) / .5 mL in 1 SYRINGE (0641-6206-01)